DUX4 and facioscapulohumeral muscular dystrophy: To test the therapeutic potential of adenine base editing in facioscapulohumeral dystrophy, we targeted the DUX4 polyadenylation signal and achieved efficient DUX4 mRNA downregulation in FSHD muscle cell cultures.